Wed, 04 Feb 2026
Novo Nordisk is facing "unprecedented" price pressures, "intensifying competition" and patents expiring.
>>
Terms of Use | Privacy Policy | Manage Cookies+ | Ad Choices | Accessibility & CC | About | Newsletters | Transcripts
Business News Top © 2024-2025